PTI Trademark

Trademark Overview


On Thursday, March 28, 2019, a trademark application was filed for PTI with the United States Patent and Trademark Office. The USPTO has given the PTI trademark a serial number of 88361172. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, May 17, 2021. This trademark is owned by Proteostasis Therapeutics, Inc.. The PTI trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cardiovascular, hematological, immunological, dermatological, central nervous system, motor neuron, cancerous, gastrointestinal, orthopedic, oncological, inflammatory, infectious, viral, asthmatic, allergic, metabolic, diabetic, transplant rejection, ophthalmic conditions, diseases, and syndromes and disorders in the nature of digestive disorders, ophthalmic disorders, hepatic disorders, respiratory disorders, sweat disorder, pancreatic disorders, reproductive disorders, and endocrine disorders; medical diagnostic assays for testing of body fluids; medical diagnostic assays for testing human cells for responses to therapy
pti

General Information


Serial Number88361172
Word MarkPTI
Filing DateThursday, March 28, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, May 17, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, February 18, 2020

Trademark Statements


Indication of Colors claimedThe color(s) white, dark blue, light blue and purple is/are claimed as a feature of the mark.
Description of MarkThe mark consists of a lotus consisting of the colors purple, dark blue and light blue, with the letters "PTI" appearing in white within the lotus.
Goods and ServicesPharmaceutical preparations for the treatment of cardiovascular, hematological, immunological, dermatological, central nervous system, motor neuron, cancerous, gastrointestinal, orthopedic, oncological, inflammatory, infectious, viral, asthmatic, allergic, metabolic, diabetic, transplant rejection, ophthalmic conditions, diseases, and syndromes and disorders in the nature of digestive disorders, ophthalmic disorders, hepatic disorders, respiratory disorders, sweat disorder, pancreatic disorders, reproductive disorders, and endocrine disorders; medical diagnostic assays for testing of body fluids; medical diagnostic assays for testing human cells for responses to therapy

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, April 16, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameProteostasis Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBoston, MA 02135

Party NameProteostasis Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBoston, MA 02135

Trademark Events


Event DateEvent Description
Monday, May 17, 2021ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, May 17, 2021ABANDONMENT - NO USE STATEMENT FILED
Saturday, September 26, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, September 24, 2020EXTENSION 1 GRANTED
Thursday, September 24, 2020EXTENSION 1 FILED
Thursday, September 24, 2020TEAS EXTENSION RECEIVED
Tuesday, April 14, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, March 6, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, March 6, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, March 6, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, March 6, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, March 6, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, February 18, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 18, 2020PUBLISHED FOR OPPOSITION
Wednesday, January 29, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, January 13, 2020ASSIGNED TO LIE
Thursday, January 9, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, January 9, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, January 9, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, January 9, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, August 23, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, August 23, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, July 19, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, July 19, 2019NON-FINAL ACTION E-MAILED
Friday, July 19, 2019NON-FINAL ACTION WRITTEN
Tuesday, July 16, 2019PREVIOUS ALLOWANCE COUNT WITHDRAWN
Tuesday, July 16, 2019WITHDRAWN FROM ISSUE - SENIOR ATTORNEY REQUEST
Tuesday, July 16, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 16, 2019PUBLISHED FOR OPPOSITION
Wednesday, June 26, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, June 8, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, June 8, 2019ASSIGNED TO EXAMINER
Wednesday, April 17, 2019NOTICE OF DESIGN SEARCH CODE E-MAILED
Tuesday, April 16, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, April 1, 2019NEW APPLICATION ENTERED IN TRAM